greeksoup/ stock research
Stock research / United States / Funds / Shah Capital Management

Shah Capital Management

CIK 1383838 · latest 13F filed 9 October 2026 · Read the filing on EDGAR

Shah Capital Management reported 11 US-listed holdings worth $605.3 million in its 13F for the quarter ended 30 September 2026, filed 9 October 2026. Its largest: Veon Ltd (56.8%), Novavax Inc. (21.7%) and China Yuchai Intl Ltd (6.8%). Against the quarter before, it opened 2 positions, added to 2, trimmed 7 and sold out of 0.

Reported holdings$605.3M+15.0% on Q2 2026
Positions11+2 on Q2 2026
The largest ten99.9%of its reported holdings
Latest 13FQ3 2026filed 9 October 2026
Where the money is
OpenedAdded toTrimmed
VEON56.8%NVAX21.7%CYD6.8%VGSH5.3%EDU2.7%TROX1.9%AM1.7%CSIQ1.7%DOL

The 11 largest of its 11 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q2 2026.

Reported holdings, quarter by quarter
Q3 2024: $513.0 million in 19 positions$513MQ3 24Q4 2024: $495.9 million in 16 positions$496MQ4 24Q1 2025: $489.6 million in 17 positions$490MQ1 25Q2 2025: $514.0 million in 14 positions$514MQ2 25Q3 2025: $559.0 million in 13 positions$559MQ3 25Q4 2025: $518.5 million in 12 positions$519MQ4 25Q1 2026: $521.2 million in 11 positions$521MQ1 26Q2 2026: $526.2 million in 9 positions$526MQ2 26Q3 2026: $605.3 million in 11 positions$605MQ3 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +69.1% over the 8 quarters to 30 September 2026, against +32.9% for the S&P 500.

Its reported holdingsThe S&P 500
100125150175Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Its holdings +69.1%S&P 500 +32.9%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Opened 2Added 2Trimmed 7
Opened: 2Added: 2Trimmed: 7

Its positions against its 13F for the quarter to 30 June 2026; a change under 0.1% of a position counts as held

Opened 2

  1. Elicio Therapeutics Inc. ELTX$2.3 million
  2. Real Remax Group Inc. Com New REAX$350,039

Added to 2

  1. Vanguard Short Term Government VGSH+179,207 shares · +47%
  2. Tronox Holdings PLC TROX+344,993 shares · +13%

Trimmed 7

  1. Novavax Inc. NVAX-2.0 million shares · -14%
  2. Veon Ltd VEON-18,406 shares · -0%
  3. Antero Midstream Corp. AM-35,117 shares · -6%
  4. China Yuchai Intl Ltd CYD-20,999 shares · -2%
  5. New Oriental Ed & Technology EDU-3,362 shares · -1%
  6. Dole PLC DOLE-13,542 shares · -3%
  7. Canadian Solar Inc. CSIQ-14,145 shares · -2%

What it holds

CompanySharesValueOf its bookChange in shares
Veon Ltd VEON4.6M$343.7 million56.78%-18.4K
Novavax Inc. NVAX12.2M$131.6 million21.74%-2.0M
China Yuchai Intl Ltd CYD1.3M$41.0 million6.77%-21.0K
Vanguard Short Term Government VGSH561.5K$32.3 million5.34%+179.2K
New Oriental Ed & Technology EDU291.5K$16.2 million2.67%-3.4K
Tronox Holdings PLC TROX2.9M$11.5 million1.90%+345.0K
Antero Midstream Corp. AM521.7K$10.5 million1.74%-35.1K
Canadian Solar Inc. CSIQ909.6K$10.5 million1.73%-14.1K
Dole PLC DOLE427.3K$5.4 million0.90%-13.5K
Elicio Therapeutics Inc. ELTX1.2M$2.3 million0.38%new
Real Remax Group Inc. Com New REAX21.4K$350,0390.06%new
Every US-listed position in the fund's 13F for the quarter ended 30 September 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before.